An update from Avinger (AVGR) is now available.
Avinger, Inc. has solidified its market presence in the Greater China region through a strategic partnership with Zylox-Tonbridge Medical Technology Co., Ltd., allowing them to license and distribute various products. This 20-year agreement, with potential extensions, includes royalties on sales and the opportunity for Avinger to bring Zylox-Tonbridge’s products to the U.S. and Germany. Additionally, Avinger has secured $15 million in funding via a Private Placement of common and preferred stock, strengthening their financial positioning and enabling further expansion and product distribution efforts.
Learn more about AVGR stock on TipRanks’ Stock Analysis page.